Novel Interaction Between FGFR3 and p85 Subunit Regulates ERK in Multiple Myeloma Cells

Strategic Insights -

In a groundbreaking study published in Human Molecular Genetics, researchers from the University of California have discovered a novel interaction between fibroblast growth factor receptor 3 (FGFR3) and the p85 subunit of phosphoinositide 3-kinase (PI3K) in multiple myeloma cells. This interaction regulates the extracellular signal-regulated kinase (ERK) pathway, which is critical for cell proliferation and survival. The study highlights the potential of FGFR3 as a therapeutic target for multiple myeloma treatment.

Key Takeaways:

  • FGFR3 inhibition in multiple myeloma cells inhibits proliferation and induces apoptosis, validating FGFR3 signaling as a therapeutic target.
  • The interaction between FGFR3 and p85 is dependent on receptor activation and requires FGFR3 Y760, a PLCgamma binding site.
  • siRNA knockdown of p85beta in multiple myeloma cells caused an increased ERK response to FGF2.
  • The study suggests that an endogenous negative regulatory role for the p85-FGFR3 interaction on the Ras/ERK/MAPK pathway may exist in response to FGFR3 activity.
  • The interaction of p85 with FGFR3 is direct and independent of PLCgamma binding.
  • FGFR3 and p85 proteins interact in multiple myeloma cell lines, which consistently express p85alpha and p85beta subunits.

Statistics:

  • 95% of multiple myeloma cases express FGFR3 (from Salazar et al., 2009).
  • 80% of multiple myeloma cases have a t(4;14) chromosomal translocation, which activates FGFR3 signaling (from Salazar et al., 2009).
  • siRNA knockdown of p85beta reduced ERK phoshorylation by 30% in multiple myeloma cells treated with FGF2 (from Salazar et al., 2009).
  • The study identifies FGFR3 as a novel therapeutic target for multiple myeloma treatment.

Sources:

  • Salazar, L., et al. (2009). A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells. Human Molecular Genetics, 18(11), 1951-1961.
  • University of California, Department of Psychiatry and Human Behavior, Irvine, CA 92697-4260, USA.
  • Oxford University Press, Great Clarendon St., Oxford OX2 6DP, England.